CytRx Corp.
(Other OTC/NBB : CYTR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
REGNRegeneron Pharmaceuticals, Inc. -1.20%723.102.6%$745.67m
AMGNAmgen, Inc. -0.70%229.331.4%$604.26m
BIIBBiogen, Inc. -1.48%258.391.8%$571.48m
MRNAModerna, Inc. -4.68%119.290.0%$562.31m
GILDGilead Sciences, Inc. -1.10%64.241.0%$544.04m
VRTXVertex Pharmaceuticals, Inc. -1.51%294.121.9%$423.43m
ILMNIllumina, Inc. -2.92%206.503.2%$398.83m
SNSSSunesis Pharmaceuticals, Inc. 1.99%4.100.7%$286.61m
SAVACassava Sciences, Inc. -6.61%39.550.0%$177.14m
BNTXBioNTech SE -1.85%134.980.0%$107.37m
TECHBio-Techne Corp. -4.80%294.254.5%$95.93m
BMRNBioMarin Pharmaceutical, Inc. -3.95%87.874.2%$92.14m
PRTAProthena Corp. Plc -3.97%56.2513.8%$76.08m
CRSPCRISPR Therapeutics AG -5.23%61.850.6%$74.13m
NVAXNovavax, Inc. -9.62%16.3475.6%$71.84m

Company Profile

CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded in 1985 and is headquartered in Los Angeles, CA.